Artificial intelligence in tobacco control: A systematic scoping review of applications, challenges, and ethical implications
Abstract
BACKGROUND
Tobacco use remains a significant global health challenge, contributing substantially to preventable morbidity and mortality. Despite established interventions, outcomes vary due to scalability issues, resource constraints, and limited reach.
OBJECTIVE
To systematically explore current artificial intelligence (AI) applications within tobacco control, highlighting their usefulness, benefits, limitations, and ethical implications.
METHOD
This scoping review followed the Arksey and O'Malley framework and PRISMA-ScR guidelines. Five major databases (PubMed, Scopus, Web of Science, IEEE Xplore, and PsycINFO) were searched for articles published between January 2010 and March 2025. From 1,172 initial records, 57 studies met inclusion criteria after screening.
RESULTS
AI-driven tools, including machine learning and natural language processing, effectively monitor social media for emerging tobacco trends and personalize smoking cessation interventions. Applications were predominantly focused on predictive modelling (using algorithms like XGBoost and SVM to predict e-cigarette use and relapse risk), cessation support (employing chatbots and reinforcement learning to improve accessibility), and social media surveillance (detecting synthetic nicotine promotions and analysing vaping trends). Approximately 22% of studies aligned with WHO FCTC Article 13 (tobacco advertising regulation), while 45% supported Article 14 (cessation services). However, tobacco industry interference…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.